Applicants must provide evidence of a Hepatitis B Panel
indicating antibodies against the virus is present or proof that a vaccination series has begun.
Not exact matches
Data from in vivo mouse models
indicate that delivery of the DMAb sequence for the influenza A-targeted monoclonal
antibody protected
against lethal doses of two very different, clinically relevant influenza A
viruses.
These so - called broadly neutralizing
antibodies (bNAbs) do little to help the people who produce them, but their existence
indicates that mutations have created an increasingly diverse population of the
virus, which in turn has pushed the immune system to evolve a response that is both more potent and works
against more variants.
In the two decades following the epidemic, wild canids died following CDV infection but fatal CDV was not observed in lions or spotted hyenas anymore, even though high prevalence of serum
antibodies against CDV in some years
indicated outbreaks of asymptomatic exposure to the
virus in lions and hyenas.
Published in the November, 2012 issue of the Journal of the American Veterinary Medical Association, «Prevalence of serum
antibody titers
against feline panleukopenia
virus, feline herpesvirus 1, and feline calicivirus in cats entering a Florida animal shelter,» presented data
indicating the majority of cats coming into a shelter do not have immunity to the common feline diseases feline panleukopenia
virus (FPV), feline herpesvirus 1 (FHV1) and feline calicivirus (FCV).